Introduction
Gliomas are the most common primitive central nervous system (CNS) tumors thought to derive from macroglial cells (astrocytes and oligodendrocytes) and/or neural progenitors. Mechanisms underlying brain tumors formation and progression are largely unknown. Aside the rapid progression of glioblastomas with a poor prognosis, low-grade gliomas slowly progress over years before they change into more aggressive stages (Wechsler-Reya and Scott, 2001) . Transforming growth factor a (TGFa) and its receptor erbB1 (or epidermal growth factor receptor) constitute one of the signalling modules most frequently deregulated in gliomas. TGFa overexpression is found in about 80% of them, and is observed from the initial steps of their development (Junier, 2000) , whereas the overexpression of erbB1 appears in 20-40% of them in later phases (Wechsler-Reya and Scott, 2001 ). We previously showed that TGFa acts as a gliatrophin on mouse and human cortical astrocytes, promoting their growth as well as their survival (Sharif et al., 2006b) , in agreement with the recent report of increased astrocyte apoptosis in erbB1 knockout mice (Wagner et al., 2006) . These results suggest that TGFa might participate in the early stages of tumoral transformation through the deregulation of astrocyte proliferation and apoptosis. However, the recent discoveries of cancerous neural stem-like cells in human gliomas, and the demonstration that neural progenitors are more sensitive than differentiated astrocytes to the transforming effects of various oncogenic manipulations, have raised the possibility that a trouble in cell differentiation might also participate to the formation of these tumors (Dai and Holland, 2003; Harris, 2004; Singh et al., 2004) . Such a possibility is supported by the consequences of the introduction of a mutated, constitutively active form of erbB1 in cultured astrocytes (Bachoo et al., 2002) . The activation of erbB1, insufficient alone to ensure wild-type astrocyte transformation, results in the dedifferentiation of cultured mutant astrocytes lacking the INK4a/ARF tumor suppressor gene locus, and their transformation into tumoral cells capable to form high-grade gliomas when transplanted in the brain (Bachoo et al., 2002) .
Interestingly, we and others noted that several days of TGFa exposure leads in vitro to morphological alterations of wild-type astrocytes, reminiscent of the bipolar shape of a population of neural progenitors, the radial glial cells (Miller et al., 1996; Zhou et al., 2001; Figiel et al., 2003; Liu and Neufeld, 2004; Sharif et al., 2006b ).
This led us to examine if exposing differentiated astrocytes to TGFa compromises the stability of their phenotype in the absence of any genetic alteration. TGFa acts as a mitogenic or differentiating factor at different steps of the pathway leading from a neural stem cell to a mature astrocyte according to the low or high levels of erbB1 expressed by the cell (Lillien, 1995; Burrows et al., 1997; Sun et al., 2005) . Any analysis of TGFa effects thus requires a careful characterization of the cell population studied. Mature astrocytes are routinely identified by their expression of the intermediate filament glial fibrillary acidic protein (GFAP). However, a distinct, much less abundant population of GFAP-expressing cells behaving as neural stem cells coexists with astrocytes in the germinal zones of the post-natal and adult brain, and possibly in non-neurogenic regions (Doetsch, 2003) . The presence of such cells has been detected at a low frequency in astrocyte cultures through their capability to form floating cellular spheres (Laywell et al., 2000; Imura et al., 2003) . Consequently, we developed culture conditions depleted of this cell type. Using these thoroughly defined primary cultures of cortical astrocytes, devoid of any residual neural progenitors or stem cells, we demonstrate that prolonged exposure of differentiated astrocytes to TGFa results in a two-step progressive and functional conversion of the cells, first into neural progenitor-like cells, and second in cells exhibiting properties of neural stem cells.
Results
TGFa induces cortical astrocytes to acquire a bipolar shape through the activation of erbB1 Astrocyte cultures (4-6 days with serum followed by 3 days in totally defined minimal medium) were established from 1-to 10-day-old C57Bl6 mouse cortices (see Materials and methods). No morphological rearrangement was noted upon serum starvation. No induced death was observed following either of the treatments performed (i.e. serum starvation, TGFa, heregulinb1 or basic fibroblast growth factor (bFGF) addition). In control conditions, astrocytes adopted a typical flat polygonal morphology with an actin network predominantly arranged as sub-cortical fibers just beneath the membrane (Figure 1a ). TGFa (10 or 50 ng/ml) initiated profound morphological rearrangements at 2-3 days in vitro (DIV), including elongation of the nucleus, retraction of the cytoplasm, extension of two opposite processes and appearance of actin stress fibers ( Figure 1b) . As TGFa treatment was prolonged, the elongation of the nucleus and the retraction of the cytoplasm were accentuated. At 7 DIV, half of the cell population (5371.4%, mean7s.e.m., n ¼ 6) presented a complete bipolar morphology with a very thin layer of cytoplasm surrounding the fusiform nucleus and two long thin processes extending in opposite directions (Figure 1c ). TGFa effect was fully reversed upon serum addition (not shown). To check for the specificity of TGFa effect, we evaluated the activation state of erbB1 that we previously evidenced to be activated up to 3 days of TGFa treatment (Sharif et al., 2006b) . We observed that the activated, phosphorylated form of erbB1 was still detected after 7 DIV in the presence of TGFa, despite downregulation of the protein levels of the receptor (Supplementary Figure 1) . In addition, TGFa-induced morphological changes were abolished upon inhibition of erbB1 tyrosine kinase activity with AG1478, as observed at 7 DIV (Figure 1d-f) . The specificity of TGFa-induced morphological changes was further demonstrated by the lack of effect of bFGF when substituted to TGFa (data not shown). We also analysed primary cultures of astrocytes derived from human embryonic cortices. In addition to erbB1 and erbB2, these astrocytes express the erbB3 receptor, activated by the heregulinb1 ligand (Sharif et al., 2006a) , another member of the epidermal growth factor (EGF) super-family. Heregulinb1 treatment did not Figure 1 TGFa induces mouse and human astrocytes to acquire a bipolar shape. (a-c) Labelling of the mouse astrocyte actin cytoskeleton with Alexa 488-coupled phalloidin. In serum-free medium, mouse astrocytes have a flat, polygonal shape (a). After 3 days in the presence of TGFa, astrocytes start to exhibit an elongation of the nucleus accompanied by cytoplasmic retraction, and adopt an elongated shape (b, arrows). After 7 days, TGFa-induced morphological rearrangements are complete and astrocytes exhibit a bipolar shape with elongation of the nucleus and extension of two thin processes running in opposite directions (c). Scale bars ¼ 20 mm. (d-f) TGFa-induced morphological changes require activation of erbB1. Morphological changes were monitored using phase-contrast microscopy. (d) Untreated astrocytes. (e) TGFa-treated astrocytes. (f) Inhibition of erbB1 activation by the specific inhibitor AG1478 abrogated TGFainduced morphological changes. Scale bars ¼ 50 mm. (g-i) Human astrocytes adopted a bipolar elongated morphology when exposed to TGFa. Actin cytoskeleton was labelled with rhodamine-coupled phalloidin. In serum-free medium, human astrocytes had a ramified stellate shape (g), which remained unchanged for 3 days in the presence of heregulinb1, a ligand of the erbB3 receptor (h). In contrast, human astrocytes responded to TGFa as mouse astrocytes by adopting a bipolar, highly elongated shape after 3 days (i). Scale bars ¼ 60 mm.
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A Sharif et al alter the overall stellate astrocyte morphology, although a thickening of the processes was noted (Figure 1g and h), whereas TGFa induced human astrocytes to acquire a bipolar shape as their mouse counterparts (Figure 1i ). These results pointed to a specific effect of TGFa on astrocyte morphology, dependent on the activation of erbB1.
TGFa-induced bipolar cells express the molecular markers of radial glial cells The bipolar morphology induced by TGFa exposure strikingly resembled that of radial glial cells, normally restricted to the developing nervous system, where they act as neural progenitors (Kriegstein and Gotz, 2003) .
We therefore examined the expression of three proteins commonly used for their in situ identification (Kriegstein and Gotz, 2003) . GLAST, a glutamate glial-specific transporter, and brain lipid-binding protein (BLBP) are expressed in vivo by radial glial cells and astrocytes in the developing brain and in vitro by astrocytes for GLAST (Feng et al., 1994; Sutherland et al., 1996) . RC2, a post-translationally modified isoform of nestin, is considered as the most specific molecular marker of radial glial cells in the mouse (Chanas-Sacre et al., 2000) , whereas nestin is expressed in all progenitors, reactive astrocytes and astrocytes grown in culture (Pekny et al., 1998) . As expected, untreated astrocytes expressed GLAST in the form of a punctuated labelling enriched at the plasma membrane (Figure 2a) , and TGFa-treated astrocytes retained a robust GLAST-immunoreactive signal (Figure 2b) . A striking upregulation of BLBP expression was observed in TGFa-induced bipolar cells (Figure 2c and d) . No RC2-immunoreactive polygonal astrocytes were observed in control conditions (Figure 2e ). In contrast, at 7 DIV 36.372.9% (mean7s.e.m., n ¼ 3) of the bipolar cells expressed RC2 in TGFa-treated cultures (Figure 2f ). TGFa-induced RC2-immunoreactive bipolar astrocytes co-expressed GLAST (Figure 2i -k) and BLBP (Figure 2l -n). GFAP expression was observed in half of the RC2-immunoreactive bipolar astrocytes ( Figure 2o -q and r-t). We also examined the expression of the transcription factor Olig2. Olig2 is a marker of neural progenitors, radial glial cells included (Kriegstein and RC2 (e, f). Nuclei were counter-stained with DAPI (blue). GLAST expression was observed in control astrocytes as punctuate staining (a), and was maintained in TGFa-induced bipolar astrocytes (b). A low BLBP-immunoreactive signal observed in control astrocytes (c) increased sharply upon TGFa action (d). Astrocytes did not express RC2 in control cultures (e), whereas RC2-immunoreactive bipolar cells were observed in TGFa-treated astrocyte cultures (f). (g, h) Immunodetection of Olig2, a marker of neural progenitors also expressed in immature astrocytes, yielded a barely detectable signal in control astrocytes (g), whereas TGFainduced bipolar astrocytes exhibited a strong nuclear-immunoreactive signal after 7 DIV (h). Double immunofluorescent labelling showed that the RC2-immunoreactive bipolar cells (red) present in TGFa-treated cultures at 7 DIV co-expressed GLAST (i-k) and BLBP (l-n). RC2-immunoreactive cells (red) either co-expressed GFAP (green) (o-q) or were devoid of GFAP-immunoreactivity (r-t). Nuclei were counter-stained with DAPI (blue). Images were obtained on a fluorescent microscope. Scale bars ¼ 20 mm.
and Gotz, 2003; Hack et al., 2004) . Olig2 inhibits the differentiation of neural progenitors into astrocytes (Fukuda et al., 2004; Muroyama et al., 2005) and its expression is downregulated in vitro and in vivo in mature astrocytes (Fukuda et al., 2004; Marshall et al., 2005) . Accordingly, a hardly detectable Olig2-immunoreactive signal was observed in control astrocytes (Figure 2g ), whereas TGFa-treated cells exhibited a strong nuclear Olig2-immunoreactive signal (Figure 2h ).
Taken together, these results showed that TGFa induces astrocytes to acquire the morphological and molecular hallmarks of radial glial cells while retaining for part of them the expression of GFAP, which is normally absent from radial glial cells in rodents (Bignami and Dahl, 1974) .
Absence of residual neural progenitors or stem cells in the control astrocyte cultures Our in vitro differentiated astrocyte cultures consisted of an adherent monolayer of 91-96% GFAP-positive cells, the complement cells (9-4%) corresponding to CD11b-positive microglial cells. The size of the population affected by TGFa and the progressiveness of the morphological alterations allowed a clear identification of GFAP-immunoreactive polygonal astrocytes as the target cells. However, previous reports, using growth factors cocktails including EGF, the functional analog of TGFa, have detected the presence of neural stem cells at a low frequency (0.1-10%) in astrocyte cultures (Laywell et al., 2000; Imura et al., 2006) . We thus verified whether residual radial glia and/or neural stem cells could account for part of our observations.
Our dissection procedure did not encompass the germinal ventricular zone where the cellular bodies of the radial glial cells are located (Kriegstein and Gotz, 2003) . Accordingly, freshly dissociated cells of post-natal day 1 cortices contained numerous GFAP-immunoreactive cells, but no RC2-immunoreactive signals (not shown). This was further confirmed by observing the same TGFa-induced morphological changes and RC2 expression on astrocyte cultures derived from the superficial layers of the cortex (compare Figure 3a and b to Figure 2e and f). We then examined the effects of TGFa on cultured astrocytes from 10-day-old cortices, as RC2-immunoreactive radial glial cells are detectable in the cortex of mice up to 5 days of age (Figure 3c ), but not at 10 days of age ( Figure 3d ). Furthermore, the numbers of neural progenitors that can be derived from the cortex at that age is known to decrease sharply as compared to 1-day-old cortex (Seaberg et al., 2005) . Again, response of astrocytes derived from 10-day-old mouse cortices to TGFa was indistinguishable from that of astrocytes derived from 1-day-old mouse cortex (compare Figure 3e and f to Figure 2e and f).
We next sought for the development of neurospheres that would testify to the presence of residual neural stem cells, reported to differentiate into radial glial cells in the presence of TGFa (Gregg and Weiss, 2003) . Astrocyte cultures, treated or not with TGFa, were trypsinized, re-suspended in serum-free medium containing TGFa and bFGF (20 ng/ml each) (Laywell et al., 2000) and further cultured for 10 days. In these conditions, we did not observe the development of cellular spheres, and trypan blue exclusion assays showed that the few floating elements detected were debris. Likewise, cellular suspensions obtained from 1-day-old post-natal cortices directly cultured in serum-free medium supplemented with TGFa and bFGF did not yield cellular spheres up to 26 DIV. On the opposite, use of neurosphere medium allowed the development of cellular spheres after 21 DIV, at a rate o1% per viable cell initially seeded, as expected for non-neurogenic brain regions (Seaberg et al., 2005) . We additionally evaluated whether the medium used for astrocyte cultures could sustain the development of already established neural stem cells. Neurosphere cultures derived from E12 mouse cortices were transferred into defined medium supplemented with TGFa. Neurospheres attached within 24 h before dying within the following 3 days (data not shown). These results demonstrate that the method we used to prepare astrocyte cultures did not allow the isolation of viable neural progenitors or stem cells.
Altogether, these results evidenced that RC2-immunoreactive bipolar cells observed in TGFa-treated cultures did not stem from the amplification by the TGFa induces the conversion of astrocytes into functional radial glial cells Acquisition of the morphology of radial glial cells as well as of the synthesis of RC2 and Olig2 are not sufficient to give proof of a functional status. The initial function assigned to radial glial cells is the support of neuronal migration from the germinal zones of the CNS towards their final locations (Rakic, 2003) . We evaluated this function using co-cultures of astrocytes derived from cortices of mice bearing an actin-green fluorescent protein (GFP) transgene, and cortical neurons derived from 16-day-old wild-type mouse embryos. Embryonic brain cellular suspension was added upon actin-GFP astrocytes seeded at low density and treated for 7 days with TGFa, and the migration of immature neurons (doublecortin positive (Francis et al., 1999) ; Figure 4b ) along the glial bipolar processes was monitored 24 h later using time-lapse microphotography as described (Gregg and Weiss, 2003) . The bipolar processes extended by TGFa-treated astrocytes supported neuronal migration (Figure 4e-i) . Of the 39 neurons monitored, 15 moved in a directional way along the bipolar glial processes at speeds ranging from 3 to 51 mm/h (mean7s.e.m.: 17.9573.16 mm/h, n ¼ 15). In contrast, neurons apposed to polygonal astrocytes did not move (double arrows, Figure 4e and i).
Radial glial cells are also recognized as an essential neural progenitor population in the developing CNS (Kriegstein and Gotz, 2003) . Cultured astrocytes initially exposed for 7 DIV to TGFa were further cultured for 18 days in neurobasal medium containing the B27 supplement and TGFa. This additional differentiating period resulted in the appearance of cells expressing the neuronal markers bIII-tubulin ( Figure 5b ) and microtubule associated protein 2 (MAP2) (Figure 5d ), absent from the control cultures (Figure 5a and c) . Neuronal markers were also absent in astrocyte cultures maintained for 7 plus 18 DIV in defined medium supplemented with TGFa (not shown). We further evaluated the functional properties of the cells transferred in neurobasal medium containing B27 and TGFa, as compared to cells never exposed to TGFa and transferred to neurobasal medium containing only B27, by characterizing their electrophysiological properties using standard whole-cell patch-clamp recordings (Figure 5e-h ). All cells recorded from TGFa-treated cultures displayed voltage-activated currents (n ¼ 25, Figure 5f1 and f2). These cells had an input resistance (R i ) ranging from 40 MO to 1.3 GO (244750.6 MO, mean7s.e.m., n ¼ 25), and an input capacitance of 14.870.8 pF (mean7s.e.m., n ¼ 25). All cells tested showed an outward delayed current (Figure 5f1 and f2 ). This current, activated mostly at À20 mV, was decreased in the presence of 10 mM tetraethylammonium (TEA) (Figure 5g ), identifying voltage-gated potassium channels. Twelve out of 25 cells also expressed voltage-gated sodium channels (holding potential V h ¼ À80 mV), characterized by a voltage-dependent inward current (Figure 5f1 and f2) , partly blocked by the application of tetrodotoxin (TTX) (E80%) (Figure 5h ). This sodium current was activated at À40 mV and reached a maximum between À10 and 0 mV (V h ¼ À80 mV). Its averaged maximal amplitude was 168.5722.3 pA (mean7s.e.m., n ¼ 12). Such a combination of voltage-gated delayed outward rectifier K þ currents and voltage-gated inward Na þ currents has been reported in differentiating neural progenitors (see (Owing to technical constraints, RC2 and doublecortin were both detected with red fluorochromes. Lack of RC2 immunolabelling in neurons apposed onto the glial bipolar processes was therefore verified before performing doublecortin labelling.) Images were acquired on a confocal microscope. Scale bar ¼ 20 mm. (e-i) Example of a neuron migrating along a process of a bipolar astrocyte. Displacements were monitored using phase-contrast time-lapse microphotography. The arrow points to a neuron attached to a bipolar astrocyte (arrowhead in (d) and (e)) and that migrates along the process. Polygonal astrocytes (asterisk in (d) and (e)) could not support directional migration of immature neurons (double arrowhead in (e) and (i)). Scale bars ¼ 50 mm. Discussion). In contrast, none of the cells cultivated in the absence of TGFa displayed voltage-activated currents (Figure 5e1 and e2, n ¼ 15). Cells in control cultures had R i values ranging from 20 to 329 MO (79.4720.5 MO, mean7s.e.m., n ¼ 15), which were significantly lower than values recorded for cells in the TGFa-treated cultures (unpaired t-test, Po0.01). Similar electrical patterns were observed whether astrocytes were in contact between each other or isolated.
Altogether, these results showed that TGFa induced the conversion of astrocytes into functional radial glial cells, able to support neuronal migration and to behave as neuroprogenitors.
TGFa-induced radial glial cells convert into neural stem-like cells upon lengthened TGFa action Development of 0.5-1 mm cellular blocks at the top of the cellular layer was observed in astrocyte cultures maintained for 10 months in TGFa-supplemented defined medium (untreated cultures died after 2 months). Blocks were collected from three different wells of two independent cultures, dissociated and the cells further cultured in six-well plates in neurosphere medium. The cells kept growing free-floating, forming cellular spheres (Figure 6a ) that multiplied and have been maintained in culture for more than 5 months. The presence of TGFa or EGF in the neurosphere medium was required for long-term maintenance of these cellular spheres. Dissociating the cellular spheres and expanding them during 12-22 successive passages further ascertained their self-renewal capabilities. Their clonal potential was determined after seeding dissociated cellular spheres at a density of 20 cells/250 ml/well. Visual observations confirmed that each well contained 5-20 cells at the time of seeding. After 1 week in vitro, 12.670.7 cellular spheres per well (mean7s.e.m., n ¼ 24) were observed, indicating that these spheres can be clonally derived. The cellular spheres were then seeded onto polyornithine-coated glass slides, and cultured for 3-7 days in 1 or 5% fetal calf serumcontaining medium (Figure 6b-g ). In these conditions, the spheres attached, and individual cells appeared Figure 5 TGFa-induced bipolar astrocytes can behave as progenitors. Astrocytes cultured for 7 days in defined medium supplemented with TGFa, and subsequently transferred to neurobasal medium for 18 days, expressed the neuronal markers bIII-tubulin (b) and MAP2 (d). Nuclei were counter-stained with DAPI (blue). Control cultures, submitted to similar conditions but never exposed to TGFa, were devoid of bIII-tubulin (a) and MAP2 (c) expression. Images were obtained on a fluorescent microscope. . Note the occurrence of a rapidly activating and rapidly inactivating inward current (red dot). This inward current is followed by a slow activating outward current (black dot). (f2) Current-voltage (I-V) relationship of the inward current (red dots) and the outward current (black dots). (g) The voltage-dependent delayed outward current was blocked by the addition of 10 mM TEA. (h) The fast-activating and fast-inactivating inward current was 79% blocked by the addition of 1 mM TTX. Traces in (f), (g) and (h) were obtained from different cells.
A Sharif et al either at their immediate limit or at further distances (Figure 6b-g ). Numerous GFAP (Figure 6b and c), Olig2 (Figure 6d and e) and nestin-immunoreactive cells (not shown) were then observed, as were lower numbers of bIII-tubulin-immunoreactive cells (Figure 6f and g ). Taken altogether, these capacities make TGFagenerated cellular spheres very similar to neural stem cells. This led us to use two-dimensional (2D) sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis to compare the pattern of expression of several hundreds of proteins from control astrocytes, 7-day TGFa-treated astrocytes, cellular spheres derived from long-term TGFa-treated astrocytes and neural stem cells derived from the cortex of 12-dayold mouse embryos. The 2D maps obtained from control astrocytes and 7-day TGFa-treated astrocytes were different, although numerous overlaps were observed as expected, as only half of the cells had responded to TGFa at that time (Supplementary Figure  2a and b) . Comparison of the protein maps using computer-assisted analysis showed a 0.44 coefficient of correlation. On the contrary, maps obtained from the cellular spheres derived from long-term treated cells did not overlap even in part with the protein patterns of control or 7-day TGFa-treated astrocytes (coefficients of correlation ¼ 0). In contrast, cellular spheres derived from long-term TGFa-treated astrocyte cultures exhibited a global pattern of protein migration very similar to neurospheres derived from embryonic cortices (coefficient of correlation ¼ 0.74), within the ranges of molecular weight (MW) and pI examined ( Figure 6h and i and Supplementary Figure 2c and d) . These results together with the fact that sphere-forming cells in astrocytic cultures exposed to TGFa for several months have self-renewal properties, the ability to be clonally derived and the potential to differentiate into cells of the neuronal lineage, demonstrated that those cells acquired properties of neural stem cells.
Discussion
The existence of a population of GFAP-expressing neural stem cells in adult germinal regions of the mammal CNS, distinct from astrocytes, is now recognized (Doetsch, 2003) . The demonstration that neurospheres, considered as signing for the presence of neural stem cells (Reynolds et al., 1992) , can be derived from astrocytes sub-cultured for a week in EGF-or EGF-and FGF-containing medium (Laywell et al., 2000; Imura et al., 2003) , has additionally pointed to the possibility that mature astrocytes themselves might behave as stem cells at least in vitro. But the brevity of the time course required to obtain neurospheres from astrocyte cultures (7 DIV) and its similarity with that required to obtain neurospheres from brain germinal zones (Reynolds et al., 1992) suggest that they correspond to GFAPexpressing neural stem cells preserved in the cortical astrocyte cultures used (Imura et al., 2006) . In contrast, in neural stem cell and progenitor-deprived cultures, we observed a slow and sequential conversion of a population of astrocytes into functional neural progenitors. In addition, we did not observe floating cellular spheres before several months of treatment. Furthermore, we obtained the same and constant proportion of converted cells, whether the cultures derived from 1-to 2-or 10-day-old mouse cortices. Indeed, a tremendous reduction of the numbers of neural stem cells that can be derived from the mouse cortex occurs between postnatal days 1 and 10, the numbers falling then almost to zero (Seaberg et al., 2005) . Lack of Olig2 expression in control cultures further supports astrocyte maturity and initial lack of progenitors. Indeed, whereas mature astrocytes lack Olig2 expression, this transcription factor is present in radial glial cells, glial-restricted progenitors and immature astrocytes (Marshall et al., 2005) , and its expression has been shown to repress astrocytes differentiation (Fukuda et al., 2004; Muroyama et al., 2005) . Serum starvation of the cultures prior growth factors addition, and possibly the repeated washes with ice-cold phosphate saline buffer initially designed to remove the microglial and oligodendroglial cells, which reside at the top of the cellular layer, might account for the lack of neural progenitors and stem cells in our astrocyte cultures. After a week exposure, TGFa-treated astrocytes share molecular markers and functional properties of radial glial cells, that is, they support the migration of neurons and give birth to neuroblasts. Indeed, TGFa-generated radial glia transferred to neuronal growth medium expressed a combination of voltage-gated delayed outward rectifier K þ currents and voltage-gated inward Na þ currents repeatedly reported in differentiating neural progenitors (Feldman et al., 1996; Jung et al., 1998; Bahrey and Moody, 2003; Fukuda et al., 2003) . In contrast, astrocytes maintained in control conditions showed the passive membrane conductances with no voltage-dependent Na þ currents as described previously for mature astrocytes (Kressin et al., 1995, reviewed by Verkhratsky and Steinhauser, 2000) . Taken as a whole, these results demonstrate that astrocytes can indeed be converted into a bona fide novel and functional cell type, that of the radial glial cells.
The actions of TGFa and erbB1 on glial cells appear complex. TGFa was first found to promote neural stem cell/progenitor proliferation both in vitro and in vivo. Further studies extended its intervention to the adoption of an astrocyte fate by the neural progenitors (reviewed by Junier, 2000) . We now demonstrate that the same molecular system is active in a bidirectional manner, as the conversion of astrocytes into progenitors also requires erbB1 activation. It is likely that the cellular context plays a major role in the biological outcome of the mobilization of the TGFa-erbB1 pathway. The distinct actions exerted by TGFa on cortical neural progenitors, mitogenic or promoting an astrocytic fate according to the developmental stage, depend on the low or high expression levels of its receptor, respectively. During the late stage of embryonic development, when gliogenesis takes over neurogenesis, it favours the preferential differentiation of neural progenitors into astrocytes over neurons, an effect mediated by enhanced expression of erbB1, and segregation of the receptors into the daughter cell that will ultimately acquire an astrocyte phenotype (Lillien, 1995; Burrows et al., 1997; Sun et al., 2005) . Interestingly, we observed that conversion of mature astrocytes into progenitor-like cells correlated with the downregulation of the wholecell erbB1 content, suggesting that modulation of the receptor levels might be part of the mechanisms by which TGFa alters the astrocyte phenotype. This possibility remains however to be demonstrated.
The very lengthened TGFa treatment required for the genesis of neural stem-like cells from astrocytes appears puzzling. One may envisage that such prolonged treatment of glial cells with a growth factor well known to participate in oncogenesis in numerous organs (Lee et al., 1995) may result in transforming events necessary for the genesis of these cellular spheres. The striking similarities between the patterns of protein expression of cellular spheres derived from the astrocyte cultures and neural stem cells derived from the 12-day-old embryonic cortex does not, however, support such a possibility.
This study uncovers a remarkable capability of astroglial cells to undergo in vitro a functional dedifferentiation in response to a single change in their extracellular environment. This property of astrocytes may be of significance for both nervous tissue repair and glial oncogenesis. In vivo, the only known example of conversion of a differentiated cell into a less mature state in the mammal nervous system is provided by Schwann cells (Raff, 2003) . Upon nerve injury, these glial cells of the peripheral nervous system de-differentiate into their immediate precursors before proliferating and differentiating into myelinating mature cells (Scherer, 1997) . Although the upregulation of the intermediate filament nestin and its isoform RC2, normally present in progenitors, and enhanced TGFa synthesis, have been reported in astrocytes following CNS injury (Frisen et al., 1995; Lin et al., 1995; Leavitt et al., 1999; Junier, 2000) , their capability to behave in situ as regenerative cells remains to be uncovered. However, contrary to Schwann cells, astrocytes do not respond to injury by entering en masse into the cell cycle, and this tight control of their proliferation (Norenberg, 1994; Dihne et al., 2001 ) might limit their in vivo plasticity. Modelling of gliomas in transgenic mice showed that neural progenitors are more sensitive than astrocytes to the oncogenic effects of genetic mutations identified in human gliomas (Dai and Holland, 2003) . Our results suggest that a deregulation of TGFa metabolism may result in an increase of neural progenitors representing new potential targets for an additional transformation event.
Materials and methods
C57Bl6/J mice (Janvier, France) were bred and housed in an air-conditioned room with free access to water and food. All experiments carried out on cells derived from human fetuses were performed in compliance with French bioethics laws. Recombinant human TGFa was obtained from AbCys and RnDSystems (Lille, France). Recombinant human bFGF was from AbCys. Recombinant human heregulinb1 was from Neomarkers (Montluc¸on, France). AG1478 was from Calbiochem (La Jolla, CA, USA).
Cell culture preparations
Cultures of mouse astrocytes were prepared from cortices of 1-to 2-, 5-and 10-day-old mice following previously described procedures (Prevot et al., 2005) in defined medium containing 10% fetal calf serum (Biowest, Nuaille´, France). Medium was changed every 3 days following washes with ice-cold phosphate-buffered saline (PBS). When confluency was reached (8-10 DIV), cultures were shaken overnight (250 r.p.m.), trypsinized and seeded on poly-L-ornithine-coated glass slides (80 000 cells/cm 2 ). The cells were further cultured for 4-6 days, with washes with ice-cold PBS preceding each medium renewal, until an 80-90% confluent cell layer had formed. The cultures were then transferred to serum-free defined medium for 3 days, before be fed with fresh defined medium containing the appropriate growth factor and drugs or the corresponding vehicles. Enrichment of the cultures in astrocytes was determined using immunocytochemical detection of GFAP (monoclonal mouse anti-GFAP antibody, 1:400, ICN, Strasbourg, France) and microglia were identified using antiCD11b receptor immunocytochemical detection (monoclonal rat Mac1 antibody, 1:200, PharMingen, Le Pont de Claix, France). Human astrocyte cultures were prepared from fetal cortices (9-12 gestational weeks), and grown on poly-D-lysinecoated plastic dishes and glass slides. The cortices were crushed on an 80 mm nylon cloth (Buisin, Clermont, France), filtered through a 20 mm Nitex cloth, and the dissociated cells were cultured in Dulbecco's modified Eagle's medium (DMEM)-F12 supplemented with 10% fetal calf serum (Invitrogen, Cergy Pontoise, France) for 1 month in 75 cm 2 culture flasks, before seeding at 50 000 cells/well in 12-well plates on coverslips for experimentation. GFAP-immunoreactive astrocytes accounted for 91-96% of the cells in all culture types. In mouse cultures, the remaining 4-9% of cells were CD11b receptor-immunoreactive microglia.
Blocks of cells detaching from the cell monolayer in astrocyte cultures exposed to TGFa for 10-12 months were taken, dissociated and further cultured in neurosphere medium (see below). The spheres were dissociated at each medium renewal (once a week). For differentiation assays, spheres were seeded onto poly-L-ornithine-coated slides and cultured for 4-8 days in the presence of 1 or 5% fetal calf serum.
Mouse 12.5-day-old embryos were used to prepare cortical neural stem cell cultures. Embryos were collected from timemated C57/Bl6 mice. The cortex was dissected and mechanically dissociated as described (Tropepe et al., 1999) . The cells were spun down and cultured in a 75 cm 2 flask at 10 cells/ml in neurosphere medium composed of a 1:1 mixture of DMEM and F12 nutrient (Invitrogen) containing 0.6% glucose, 2 mM glutamine, 13 mM sodium bicarbonate, 5 mM N-2-hydroxyethylpiperazine-N 0 -2-ethanesulfonic acid (HEPES) buffer, 5 IU/ml penicillin and 5 mg/ml streptomycin, and the B27, N-2 and G5 supplements (10 ml/ml each, Invitrogen). Cells were passaged once a week by centrifugation at 172 g for 10 min, followed by mechanical re-dissociation and re-plating in the neurosphere medium described above.
Characterization of the morphological effect of TGFa Control and TGFa-treated (50 ng/ml) cultures were monitored daily for morphological changes under phase-contrast microscopy. Ten nanograms per milliliter TGFa also proved to be efficient, but the highest concentration was used to minimize the frequency of the medium renewals. After fixation in 4% paraformaldehyde, actin was labelled with phalloidin coupled to Alexa 488 or rhodamine (1/1500, Molecular Probes, Cergy Pontoise, France). Nuclei were counterstained with 4 0 ,6 0 -diamidino-2-phenylindole (DAPI) or Hoechst. Cultures were treated for 7 days with AG1478 (1 mM) in the presence or absence of TGFa.
Immunolabelling
Immunocytochemical and immunohistochemical procedures were performed as described (Sharif et al., 2004) 
Image acquisition
Immunofluorescence was observed with a fluorescent microscope (Eclipse E800, Nikon, USA). Images were acquired on a digital still camera (DXM 1200, Nikon, ChampignySur-Marne, France) using Lucia software (Laboratory Imaging Ltd., Nikon, Champigny-Sur-Marne, France). We used custom-made filters (Chroma, Rockingham, VT, USA): the excitation wavelengths were 440-480 nm for Alexa 488, 530-545 nm for CY3 and Texas red, and 340-380 for DAPI. The emission wavelengths were 535-550 nm for Alexa 488, 620-660 nm for CY3 and Texas red, and 435-485 nm for DAPI. Texas red-coupled phalloidin was acquired using a fluorescent system (DMRB microscope, DC300FX camera, FW4000 software, Leica, Bensheim, Germany). For confocal immunofluorescence, samples were observed using a Leica TCS SP2 confocal microscope. Two lasers were used depending on the fluorochrome. The excitation wavelengths were 543 nm for Texas red and rhodamine and 488 nm for GFP, and the emission wavelengths were 580-660 nm for Texas red and rhodamine and 500-550 nm for GFP. Samples were observed with the 40 and 63 Å objectives, with the 1.25 and 1.32 numerical aperture lenses, respectively (Leica, Germany). The pinhole was set on the airy spot and the images were acquired in a sequential scan mode for double immunofluorescent labelling. The images were prepared using Adobe Photoshop software (Adobe Systems, San Jose, CA, USA).
Neuronal migration assay
Astrocytes derived from cortices of 1-to 2-day-old transgenic mice expressing GFP under the control of the actin promoter (Hadjantonakis et al., 1998) were seeded at a density of 26 000 cells/cm 2 and treated for a week in defined medium supplemented or not supplemented with TGFa. Neurons were prepared from cortices of C57Bl6 embryos at E16 following previously described procedures (Francis et al., 1999) . They were seeded onto the astrocyte monolayer at a density of 260 000 cells/cm 2 and further maintained for up to 4 days in defined medium containing or not containing TGFa. Astrocytes were visualized by their green fluorescence, and neuronal migration was followed using phase-contrast timelapse microphotography using an inverted microscope (Leica). Images were acquired on a Photometrics CoolSNAP camera (Roper Scientific Inc., Evry, France) using MetaVue software (Molecular Devices Corporation, Sunnyvale, CA, USA). Cells were then gently fixed in paraformaldehyde and subjected to immunocytochemical labelling.
Neuronal differentiation assay
Astrocytes were treated for 7 days in the absence or presence of TGFa, before transfer for 18 days to neurobasal medium supplemented with glutamax (200 mM), B27 (20 ml/ml), 5 IU/ ml penicillin and 5 mg/ml streptomycin (Invitrogen), in the presence or absence of TGFa. Cells were then subjected to electrophysiological recordings, and to bIII-tubulin and MAP2 immunolabelling.
Electrophysiological recordings
Standard whole-cell recordings (Hamill et al., 1981) from glial cells were made under direct visualization (Nikon Optiphot microscope). The cell culture was continuously perfused at room temperature (201C) in a recording chamber (0.5 ml) with an oxygenated bathing solution (2 ml/min) containing (in mM): NaCl 145; KCl 1.5; CaCl 2 2; MgCl 2 1; glucose 10, HEPES 10 (pH 7.3) with the osmolarity adjusted to 300 mosM. Patchclamp electrodes were pulled from thick-wall borosilicate glass (GC150F-10: CEI, Harvard Apparatus Ltd., Kent, UK), fire-polished and filled with (in mM): CsCl 135 or KCl 135; MgCl 2 2; Na 3 ATP 4; ethyleneglycol tetracetate 10; HEPES 10 (pH 7.2) (290 mosM). Electrodes had resistances of 2-4 MO. Currents were recorded using an Axopatch 200B amplifier (Axon Instruments, Sunnyvale, CA, USA), filtered at 5 kHz and stored using a digital tape recorder (DAT DTR 1201, Sony, Tokyo, Japan). Series resistances (6-20 MO) were 60-80% compensated. Recordings with a series resistance >20 MO were rejected. Voltage command pulses were generated using pClamp9 software (Axon Instruments). Currents were recorded at a sampling frequency of 40 kHz and transferred onto a G4 Macintosh computer. The quality of the seal was verified for each cell having a low R i . Analysis was performed using Axograph 4.9 software (Axon Instruments) after digital filtering of the traces at 1-4 kHz. Leakage and capacitive currents were digitally subtracted. TEA (10 mM ) and 1 mM TTX (Sigma, Lyon, France) were applied to the bath using a single barrel connected to a manifold with reservoirs filled with different solutions.
Immunoprecipitation and Western blot analyses of erbB1 and erbB2 erbB1 and erbB2 expression and activation upon TGFa application were analysed following previously described procedures (Prevot et al., 2005) . Activated forms of erbB1 and erbB2 were detected using immunoprecipitation of the proteins with their respective antibodies, followed by immunoblotting with anti-phosphotyrosine antibodies. Detection of the whole protein levels of the receptors was achieved by direct Western blot analysis of the protein lysates.
2D proteomic analysis
Cells were washed three times with PBS for 10 min with gentle shaking, before lysis in buffer containing 8 M urea, 4% 3-[(3-cholamidopropyl)-dimethylammonio]-2-hydroxy-1-propanesulfonic acid and 40 mM Tris. The samples were shaken for 1 h and centrifuged for 20 min at 16 000 g. The protein pellets were dissolved in isoelectric focusing buffer and quantified using the Micro BCA protein assay kit (Pierce, Brebieres, France). Firstdimension isoelectric focusing was performed with the Ettan IPGphor system (Amersham Biosciences, Saclay, France) at 201C with a maximum current setting of 50 mA/strip. Immobiline DryStrip gels (IPG stripes, Amersham Biosciences) with a pH gradient of 3-10 or 4-7 and a length of 13 cm were rehydrated in 250 ml sample solution, containing 80 mg proteins. Series of voltage steps were applied until 16 kVh was reached (step-and-hold at 100 V for 30 min, then 1000 V gradient for 30 min, followed by a 5000 V gradient for 60 min, and terminated with step-and-hold at 8000 V). Before SDS-PAGE analysis, IPG stripes were equilibrated in second-dimension equilibration buffer (6 M urea, 2% SDS, 50 mM Tris-HCl, pH 8.8, 30% glycerol) containing 1% dithiothreitol (Sigma) to reduce the disulfide bonds of the proteins. After 15 min, the solution was replaced by equilibration solution containing 4% iodoacetamide (Sigma) and incubated for another 15 min in the dark at room temperature. The second dimension was carried out using 12.5% gradient polyacrylamide gels at constant 20 mA current per gel. Comparison of the protein maps was achieved using the PDQuest software according to the manufacturer instructions (BioRad, Marnes-la-Coquette, France).
